Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1982 Apr;48(1):121–128.

Cell-mediated immune functions and immunoregulatory cells in Behçet's syndrome.

R M Victorino, P Ryan, G R Hughes, H J Hodgson
PMCID: PMC1536574  PMID: 6211313

Abstract

Lymphocyte responsiveness to mitogens (phytohaemagglutinin (PHA), concanavalin A (Con A), and pokeweed mitogen (PWM)), T-cell subsets (T mu and T gamma) and short-lived suppressor cell activity were investigated in the peripheral blood of seven patients with Behçet's syndrome and compared to normal individuals and patients with systemic lupus erythematosus (SLE). Amongst patients with Behçet's syndrome, responses to mitogens PHA and Con A were normal or slightly reduced; numbers of circulating T gamma cells were unaltered whereas T mu cells were reduced (P less than 0 . 05) compared with normal individuals. This was in contrast to SLE where a marked reduction in responses to PHA and Con A was found with reduced T gamma cell but normal T mu cell numbers. Although the mean suppressor cell activity in the Behçet's group was significantly reduced, all patients had values within the normal range, in contrast with SLE where the reduction was much more marked and most patients had values below the normal range. In conclusion, the pattern of alteration in T mu and T gamma cells in Behçet's syndrome is distinct from that in SLE, and the reduction of short-lived suppressor cell activity is only mild in Behçet's syndrome but marked in SLE.

Full text

PDF
121

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdou N. I., Schumacher H. R., Colman R. W., Sagawa A., Hebert J., Pascual E., Carroll E. T., Miller M., South M. A., Abdou N. L. Behçet's disease: possible role of secretory component deficiency, synovial inclusions, and fibrinolytic abnormality in the various manifestations of the disease. J Lab Clin Med. 1978 Mar;91(3):409–422. [PubMed] [Google Scholar]
  2. Alarcón-Segovia D., Ruíz-Argüelles A. Decreased circulating thymus-derived cells with receptors for the Fc portion of immunoglobulin G in systemic lupus erythematosus. J Clin Invest. 1978 Dec;62(6):1390–1394. doi: 10.1172/JCI109260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bresnihan B., Jasin H. E. Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus. J Clin Invest. 1977 Jan;59(1):106–116. doi: 10.1172/JCI108607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gupta R. C., O'Duffy J. D., McDuffie F. C., Meurer M., Jordon R. E. Circulating immune complexes in active Behçet's disease. Clin Exp Immunol. 1978 Nov;34(2):213–218. [PMC free article] [PubMed] [Google Scholar]
  5. Gupta S., Good R. A. Subpopulations of human T lymphocytes. I. Studies in immunodeficient patients. Clin Exp Immunol. 1977 Nov;30(2):222–228. [PMC free article] [PubMed] [Google Scholar]
  6. Hodgson H. J., Wands J. R., Isselbacher K. J. Alteration in suppressor cell activity in chronic active hepatitis. Proc Natl Acad Sci U S A. 1978 Mar;75(3):1549–1553. doi: 10.1073/pnas.75.3.1549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hodgson H. J., Wands J. R., Isselbacher K. J. Decreased suppressor cell activity in inflammatory bowel disease. Clin Exp Immunol. 1978 Jun;32(3):451–458. [PMC free article] [PubMed] [Google Scholar]
  8. Kaplan M. E., Clark C. An improved rosetting assay for detection of human T lymphocytes. J Immunol Methods. 1974 Jul;5(2):131–135. doi: 10.1016/0022-1759(74)90003-9. [DOI] [PubMed] [Google Scholar]
  9. Lehner T. Behçet's syndrome and autoimmunity. Br Med J. 1967 Feb 25;1(5538):465–467. doi: 10.1136/bmj.1.5538.465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lehner T. Characterization of mucosal antibodies in recurrent aphthous ulceration and Behcet's syndrome. Arch Oral Biol. 1969 Jul;14(7):843–853. doi: 10.1016/0003-9969(69)90174-5. [DOI] [PubMed] [Google Scholar]
  11. Levinsky R. J., Lehner T. Circulating soluble immume complexes in recurrent oral ulceration and Behçet's syndrome. Clin Exp Immunol. 1978 May;32(2):193–198. [PMC free article] [PubMed] [Google Scholar]
  12. Moretta A., Mingari M. C., Santoli D., Perlmann P., Moretta L. Human T-lymphocyte subpopulations: alterations in systemic lupus erythematosus. Scand J Immunol. 1979;10(3):223–228. doi: 10.1111/j.1365-3083.1979.tb01343.x. [DOI] [PubMed] [Google Scholar]
  13. Moretta L., Webb S. R., Grossi C. E., Lydyard P. M., Cooper M. D. Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG. J Exp Med. 1977 Jul 1;146(1):184–200. doi: 10.1084/jem.146.1.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Morimoto C., Reinherz E. L., Schlossman S. F., Schur P. H., Mills J. A., Steinberg A. D. Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. J Clin Invest. 1980 Nov;66(5):1171–1174. doi: 10.1172/JCI109948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pussell B. A., Lockwood C. M., Scott D. M., Pinching A. J., Peters D. K. Value of immune-complex assays in diagnosis and management. Lancet. 1978 Aug 12;2(8085):359–364. doi: 10.1016/s0140-6736(78)92954-9. [DOI] [PubMed] [Google Scholar]
  16. Rogers R. S., 3rd, Sams W. M., Jr, Shorter R. G. Lymphocytotoxicity in recurrent aphthous stomatitis. Lymphocytotoxicity for oral epithelial cells in recurrent aphthous stomatitis and Bechet syndrome. Arch Dermatol. 1974 Mar;109(3):361–363. [PubMed] [Google Scholar]
  17. Sagawa A., Abdou N. I. Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction. J Clin Invest. 1978 Oct;62(4):789–796. doi: 10.1172/JCI109190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sakane T., Steinberg A. D., Green I. Studies of immune functions of patients with systemic lupus erythematosus. I. Dysfunction of suppressor T-cell activity related to impaired generation of, rather than response to, suppressor cells. Arthritis Rheum. 1978 Jul-Aug;21(6):657–664. doi: 10.1002/art.1780210608. [DOI] [PubMed] [Google Scholar]
  19. Sampson D. Studies on levamisole, a potentially useful drug in the treatment of Behçet's syndrome. J Oral Pathol. 1978;7(6):383–386. doi: 10.1111/j.1600-0714.1978.tb01606.x. [DOI] [PubMed] [Google Scholar]
  20. Shimizu T., Ehrlich G. E., Inaba G., Hayashi K. Behçet disease (Behçet syndrome). Semin Arthritis Rheum. 1979 May;8(4):223–260. doi: 10.1016/0049-0172(79)90004-0. [DOI] [PubMed] [Google Scholar]
  21. Strelkauskas A. J., Callery R. T., McDowell J., Borel Y., Schlossman S. F. Direct evidence for loss of human suppressor cells during active autoimmune disease. Proc Natl Acad Sci U S A. 1978 Oct;75(10):5150–5154. doi: 10.1073/pnas.75.10.5150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Victorino R. M., Hodgson H. J. Alteration in T lymphocyte subpopulations in inflammatory bowel disease. Clin Exp Immunol. 1980 Jul;41(1):156–165. [PMC free article] [PubMed] [Google Scholar]
  23. Victorino R. M., Hodgson H. J. Relationship between T cell subpopulations and the mitogen responsiveness and suppressor cell function of peripheral blood mononuclear cells in normal individuals. Clin Exp Immunol. 1980 Dec;42(3):571–578. [PMC free article] [PubMed] [Google Scholar]
  24. Waldmann T. A., Broder S. Suppressor cells in the regulation of the immune response. Prog Clin Immunol. 1977;3:155–199. [PubMed] [Google Scholar]
  25. Williams B. D., Lehner T. Immune complexes in Behçet's syndrome and recurrent oral ulceration. Br Med J. 1977 May 28;1(6073):1387–1389. doi: 10.1136/bmj.1.6073.1387. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES